Exploring the link between body weight and quality of life in cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate how body mass index (BMI) relates to health-related quality of life (HR-QoL) in patients with solid tumors. It will assess the association between BMI and HR-QoL using the EORTC QLQ-C30 questionnaire across various cancer settings, including localized and metastatic cancers. The study will include patients over 18 years old with a confirmed diagnosis of solid tumors and will exclude those unable to complete the questionnaire or with second malignancies that could skew results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Histologically confirmed diagnosis of solid tumor
2. Age \>18 years
3. Signed informed consent
4. Life expectancy \> 12 weeks

Exclusion Criteria:

1. Inability to fill out the questionnaires.
2. Absence of a certain diagnosis of solid tumor (e.g. subjects on screening programs)
3. Diagnosis of second malignancies that might bias results interpretation

Where it's running

• Tor Vergata University Hospital
  Rome, Italy Recruiting

Study contacts

• Study coordinator: Vincenzo Formica, MD, PhD
• Email: v.formica1@gmail.com
• Phone: +390620908190

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PIOMI plus time‑based feeding to help preterm babies start oral feeds and gain weight

  We will test whether a specific oral‑motor routine (PIOMI) and a time‑based (chronobiological) feeding approach help preterm infants born at 29–33 weeks begin oral feeding sooner and gain weight better.

  Recruiting Aydin Adnan Menderes University · Aydin · NCT07306793

• Calderasib (MK-1084) with or without cetuximab for advanced KRAS G12C solid tumors

  This study will test whether calderasib (MK-1084), alone or combined with cetuximab, can shrink advanced solid tumors in people whose cancers have the KRAS G12C mutation.

  Recruiting at 71 sites Phase 2 Merck Sharp & Dohme LLC · Baltimore, Maryland and 71 other locations · NCT07209111

• Creating tumor models to test new cancer treatments

  This study is trying to see how well new cancer treatments work on tumor samples from patients with specific mutations.

  Recruiting Centre Antoine Lacassagne · Nice · NCT06782451

• Evaluating liquid biopsy for cancer diagnosis

  This study tests if a blood test that looks for cancer DNA can help doctors find problems in patients with advanced cancer, comparing it to the usual tissue tests.

  Recruiting Centre Antoine Lacassagne · Nice · NCT06606366

• A new approach to tackle childhood obesity

  This study is testing a new program in Spain that helps kids aged 6 to 16 with obesity by changing their diets, encouraging exercise, and getting their families involved to see if it improves their health and mobility.

  Recruiting Universidad de Córdoba · Córdoba · NCT06409962

• Effects of diet on sperm DNA changes in men

  This study tests how eating a high-fat diet affects the DNA in sperm of healthy men aged 20-35 to see if it relates to obesity and metabolic health.

  Recruiting Pennington Biomedical Research Center · Baton Rouge, Louisiana · NCT06252922

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.